Matthews Judith M. 4
4 · Iterum Therapeutics plc · Filed Jan 27, 2021
Insider Transaction Report
Form 4
Matthews Judith M.
Chief Financial Officer
Transactions
- Award
Ordinary Shares
2021-01-25+62,500→ 62,500 total - Sale
Ordinary Shares
2021-01-26$1.73/sh−33,868$58,592→ 28,632 total
Footnotes (2)
- [F1]Consists of 62,500 ordinary shares received upon vesting of performance-based stock units ("PSUs") on January 25, 2021, which PSUs were subject to performance conditions that have been satisfied. PSUs convert into ordinary shares on a one-for-one basis.
- [F2]Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the PSUs. This sale does not represent a discretionary trade by the reporting person.